Magnet surgery: a new way to treat obesity and diabetes?

NCT ID NCT06232746

Completed Disease control Sponsor: GT Metabolic Solutions, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new magnetic device that creates a connection between two parts of the small intestine, bypassing some of the digestive tract. The goal was to see if this procedure is safe and feasible for adults with obesity and type 2 diabetes. Only 9 people took part, and the study focused on whether the device could be placed correctly and create a working connection without major complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetic anastomosis device (DI Biofragmentable Magnet System)
What this could lead to: If successful, this could offer a less invasive surgical option to help with weight loss and improve blood sugar control in people with obesity and type 2 diabetes.
What could go wrong: This is a very small, early feasibility study with only 9 participants. The device may not work as intended, and there are risks like bowel perforation, obstruction, or bleeding. Long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY TYPE 2 DIABETES

Contacts and locations

Locations

OB KLINIKA a.s.

Prague, 130 00, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.